CANbridge Pharmaceuticals - Bamboo Works - China stock insights for global investors https://thebambooworks.com/tag/canbridge-pharmaceuticals/ China stock insights for global investors Fri, 17 May 2024 02:03:32 +0000 en-GB hourly 1 https://wordpress.org/?v=6.1.1 https://thebambooworks.com/wp-content/uploads/2022/12/cropped-BBW_website_icon_20221228-32x32.png CANbridge Pharmaceuticals - Bamboo Works - China stock insights for global investors https://thebambooworks.com/tag/canbridge-pharmaceuticals/ 32 32 B&K Corp eyes IPO to keep its slow-developing drugs alive https://thebambooworks.com/bk-corp-seeks-ipo-to-keep-its-slow-developing-drugs-alive/ Thu, 16 May 2024 03:11:05 +0000 https://thebambooworks.com/?p=32055 The company focuses on wound-healing PDGF drugs and its core product, Pro-101-2, isn’t expected to enter Phase 3 clinical trials for at least three more years Key Takeaways: 　 By Molly Wen A recent rally that’s seen Hong Kong stocks charge into rare bull territory is injecting new life into the exchange’s moribund IPO market......

The post B&K Corp eyes IPO to keep its slow-developing drugs alive appeared first on Bamboo Works.

]]> Jiangsu Recbio Shoots to Become Hong Kong’s First HPV Vaccine Stock https://thebambooworks.com/jiangsu-recbio-shoots-to-become-hong-kongs-first-hpv-vaccine-stock/ Thu, 27 Jan 2022 09:14:42 +0000 https://thebambooworks.com/?p=3882 The vaccine producer is making a second attempt to list in Hong Kong, as its core HPV vaccine undergoes Phase 3 clinical trials Key takeaways: Jiangsu Recbio has filed a second IPO application to list in Hong Kong, hoping to become the first HPV vaccine maker in the market The company was valued at around.....

The post Jiangsu Recbio Shoots to Become Hong Kong’s First HPV Vaccine Stock appeared first on Bamboo Works.

]]>